Merus NV
MRUS90.000USD
0.0000.00%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
6.83B시가총액
손실P/E TTM
자세한 내용은 Merus NV 회사
Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's products engage cancer antigens and harness the power of the immune system to kill tumor cells by utilizing technology platform. One of the drug zenocutuzumab (Zeno), a Biclonics antibody, concentrates on helping patients with lung, pancreatic and other types of solid tumors. The company operates in the Netherlands and United States.
Merus NV 정보
종목 코드 MRUS
회사 이름Merus NV
상장일May 19, 2016
CEOLundberg (Sven Ante)
직원 수260
유형Ordinary Share
회계 연도 종료May 19
주소Yalelaan 62
도시UTRECHT
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Netherlands
우편 번호3584 CM
전화310302538800
웹사이트https://merus.nl/
종목 코드 MRUS
상장일May 19, 2016
CEOLundberg (Sven Ante)
Merus NV의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Sven Ante (Bill) Lundberg, M.D.
Dr. Sven Ante (Bill) Lundberg, M.D.
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
168.44K
-30297.00%
Mr. Mark T. Iwicki
Mr. Mark T. Iwicki
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Peter B. Silverman, J.D.
Mr. Peter B. Silverman, J.D.
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
--
--
Dr. Anand Mehra, M.D.
Dr. Anand Mehra, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Gregory D. (Greg) Perry
Mr. Gregory D. (Greg) Perry
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Leonard (Len) Kanavy
Mr. Leonard (Len) Kanavy
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Paolo Pucci
Mr. Paolo Pucci
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Victor Sandor, M.D.
Dr. Victor Sandor, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Sherri Spear
Ms. Sherri Spear
Investor Relations and Corporate Communications
Investor Relations and Corporate Communications
--
--
Dr. Maxine Gowen, Ph.D.
Dr. Maxine Gowen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Sven Ante (Bill) Lundberg, M.D.
Dr. Sven Ante (Bill) Lundberg, M.D.
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
168.44K
-30297.00%
Mr. Mark T. Iwicki
Mr. Mark T. Iwicki
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Peter B. Silverman, J.D.
Mr. Peter B. Silverman, J.D.
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
--
--
Dr. Anand Mehra, M.D.
Dr. Anand Mehra, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Gregory D. (Greg) Perry
Mr. Gregory D. (Greg) Perry
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Leonard (Len) Kanavy
Mr. Leonard (Len) Kanavy
Non-Executive Independent Director
Non-Executive Independent Director
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Sat, Jan 3
마지막 업데이트: Sat, Jan 3
주주
주주 유형
주주
주주
비율
Paradigm BioCapital Advisors LP
5.77%
Avoro Capital Advisors LLC
4.67%
Commodore Capital LP
4.65%
Deerfield Management Company, L.P.
4.02%
HBK Investments, L.P.
3.76%
기타
77.14%
주주
주주
비율
Paradigm BioCapital Advisors LP
5.77%
Avoro Capital Advisors LLC
4.67%
Commodore Capital LP
4.65%
Deerfield Management Company, L.P.
4.02%
HBK Investments, L.P.
3.76%
기타
77.14%
주주 유형
주주
비율
Hedge Fund
39.38%
Investment Advisor/Hedge Fund
27.56%
Investment Advisor
13.49%
Research Firm
2.54%
Corporation
1.93%
Private Equity
1.78%
Venture Capital
1.47%
Pension Fund
0.56%
Bank and Trust
0.49%
기타
10.81%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
498
69.89M
92.15%
-15.18M
2025Q3
434
77.32M
101.98%
-5.60M
2025Q2
411
75.46M
99.77%
-10.50M
2025Q1
420
74.82M
101.12%
-10.15M
2024Q4
398
74.69M
108.18%
-7.45M
2024Q3
373
72.99M
107.03%
-6.71M
2024Q2
355
69.91M
103.77%
+7.77M
2024Q1
315
57.35M
97.63%
-5.32M
2023Q4
282
57.36M
99.41%
-5.55M
2023Q3
268
57.60M
100.50%
+2.76M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Paradigm BioCapital Advisors LP
4.37M
5.77%
+91.82K
+2.14%
Sep 30, 2025
Avoro Capital Advisors LLC
3.54M
4.67%
+386.94K
+12.26%
Sep 30, 2025
Commodore Capital LP
3.52M
4.65%
--
--
Sep 30, 2025
Deerfield Management Company, L.P.
3.05M
4.02%
-337.71K
-9.98%
Sep 30, 2025
HBK Investments, L.P.
2.85M
3.76%
+2.85M
--
Sep 30, 2025
Westfield Capital Management Company, L.P.
2.13M
2.81%
+90.10K
+4.41%
Sep 30, 2025
RTW Investments L.P.
2.03M
2.67%
-1.98M
-49.38%
Sep 30, 2025
Fidelity Management & Research Company LLC
1.94M
2.55%
-4.28M
-68.87%
Sep 30, 2025
Woodline Partners LP
1.67M
2.21%
+131.27K
+8.51%
Sep 30, 2025
Glazer Capital, LLC
1.62M
2.13%
+1.62M
--
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Tue, Dec 2
마지막 업데이트: Tue, Dec 2
이름
비율
AltShares Merger Arbitrage ETF
3.3%
NYLI Merger Arbitrage ETF
3.1%
ALPS Medical Breakthroughs ETF
2.89%
Goldman Sachs Hedge Industry VIP ETF
2.75%
ProShares Merger ETF
2.74%
First Trust IPOX Europe Equity Opportunities ETF
2.61%
Tema Oncology ETF
2.61%
Invesco Dorsey Wright Healthcare Momentum ETF
1.4%
Harbor Health Care ETF
1.29%
AltShares Event-Driven ETF
1.23%
더 보기
AltShares Merger Arbitrage ETF
비율3.3%
NYLI Merger Arbitrage ETF
비율3.1%
ALPS Medical Breakthroughs ETF
비율2.89%
Goldman Sachs Hedge Industry VIP ETF
비율2.75%
ProShares Merger ETF
비율2.74%
First Trust IPOX Europe Equity Opportunities ETF
비율2.61%
Tema Oncology ETF
비율2.61%
Invesco Dorsey Wright Healthcare Momentum ETF
비율1.4%
Harbor Health Care ETF
비율1.29%
AltShares Event-Driven ETF
비율1.23%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
